Retraction
MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7
Paper Information
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0282985Citations (31)
31
Total Citations2
Post-Retraction(6.5%)
28
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
366
Days since retraction (latest)
The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies
Elena Chatzikalil, Ioanna Ε. Stergiou, Stavros P. Papadakos et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Mar 2024
4 citations
4 citations
366 days after retraction
The Eph/Ephrin system in primary bone tumor and bone cancer pain
Lujuan Wang, Wei Li, Yong Pan
Aging
Open Access
Published: Jul 2023
2 citations
2 citations
99 days after retraction
Retraction: MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7
Unknown Authors
PLoS ONE
Open Access
Published: Mar 2023
Same day as retraction
The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
Wenfan Zhang, Huiling Cao, Jin‐Hao Yang et al. (7 authors)
BMC Cancer
Open Access
Published: Jun 2022
16 citations
16 citations
293 days before retraction
miRNA-448 Regulates the Development of Glioblastoma (GBM) by Regulating Rho-Associated Protein Kinase 1
Liu Chang, Bin Zhu, Meng Zhong et al. (4 authors)
Computational and Mathematical Methods in Medicine
Open Access
Published: Mar 2022
4 citations
4 citations
391 days before retraction
The role of EphA7 in different tumors
Xiangyi Chen, Dechen Yu, Haiyu Zhou et al. (10 authors)
Clinical & Translational Oncology
Published: Feb 2022
10 citations
10 citations
420 days before retraction
Loss of EphA7 Expression in Basal Cell Carcinoma by Hypermethylation of CpG Islands in the Promoter Region
Jie Liu, Na Yu, Feng Xiao et al. (7 authors)
Analytical Cellular Pathology
Open Access
Published: Jan 2022
5 citations
5 citations
431 days before retraction
Protein tyrosine phosphatase non-receptor type 12 suppresses tumor progression in osteosarcoma cells
Xinwu Wang, Xinwen Wang, Jiankun Lai et al. (6 authors)
Journal of Orthopaedic Science
Published: Jan 2022
3 citations
3 citations
434 days before retraction
Evolution of the ErbB gene family and analysis of regulators of Egfr expression during development of the rat spinal cord
Xiaosong Gu, Jian Yang, Yu Zhang et al. (11 authors)
Neural Regeneration Research
Open Access
Published: Jan 2022
1 citation
1 citation
452 days before retraction
The Identification and Validation of EphA7 Hypermethylation, a Novel Biomarker, in Cervical Cancer
Wenfan Zhang, Huiling Cao, Jing Zhao et al. (7 authors)
Research Square (Research Square)
Published: Nov 2021
2 citations
2 citations
502 days before retraction
Crystal structure of clinically reported mutations Gly656Arg, Gly656Glu and Asp751His identified in the kinase domain of EphA7
Shubhashish Chakraborty, Ashok K. Varma
Biochemical and Biophysical Research Communications
Published: Jun 2021
2 citations
2 citations
641 days before retraction
Research Progress on the Role of miRNA-448 in Tumor
Changliang Jiao, Cheng‐Ta Yang, Xingjun Tan et al. (6 authors)
Journal of Cancer Therapy
Open Access
Published: Jan 2021
817 days before retraction
Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
Yangmao Tu, Qing Cai, Xuemei Zhu et al. (4 authors)
Brazilian Journal of Medical and Biological Research
Open Access
Published: Jan 2021
13 citations
13 citations
817 days before retraction
Circular <scp>RNAs</scp> in childhood‐related diseases and cancers: A review
Liwei Mao, Jianmin Guo, Linghui Hu et al. (7 authors)
Cell Biochemistry and Function
Published: Dec 2020
5 citations
5 citations
826 days before retraction
The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment
Oscar J Buckens, Btissame El Hassouni, Elisa Giovannetti et al. (4 authors)
Expert Opinion on Investigational Drugs
Open Access
Published: Apr 2020
60 citations
60 citations
1064 days before retraction
The regulatory functions of circular RNAs in osteosarcoma
Negin Soghli, Durdi Qujeq, Tooba Yousefi et al. (4 authors)
Genomics
Published: Mar 2020
40 citations
40 citations
1093 days before retraction
Effect of up‐regulation of circMATR3 on the proliferation, metastasis, progression and survival of hypopharyngeal carcinoma
Zhanwang Wang, Peng Wei, Dongmin Wei et al. (13 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Mar 2020
15 citations
15 citations
1112 days before retraction
Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data
João Lobo, Ad Gillis, Annette van den Berg et al. (14 authors)
Cells
Open Access
Published: Dec 2019
94 citations
94 citations
1201 days before retraction
MicroRNA-146a negatively regulates IL-33 in activated group 2 innate lymphoid cells by inhibiting IRAK1 and TRAF6
Beili Lyu, Zicheng Wei, Lei Jiang et al. (6 authors)
Genes and Immunity
Published: Aug 2019
28 citations
28 citations
1316 days before retraction
miR‑448 promotes progression of non‑small‑cell lung cancer via targeting SIRT1
Hongfeng Qi, Haifeng Wang, Dabin Pang
Experimental and Therapeutic Medicine
Open Access
Published: Jul 2019
20 citations
20 citations
1363 days before retraction
Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2
Shenglong Li, Yi Pei, Wei Wang et al. (6 authors)
Cell Cycle
Open Access
Published: May 2019
67 citations
67 citations
1407 days before retraction
miRNA signatures in childhood sarcomas and their clinical implications
G. M. Viera, Karina Bezerra Salomão, Graziella Ribeiro de Sousa et al. (7 authors)
Clinical & Translational Oncology
Published: Apr 2019
15 citations
15 citations
1455 days before retraction
microRNA‐448 inhibits the progression of non‐small–cell lung cancer through regulating IRS2
Jie Gao, Xiaojing Feng, Fang Wang et al. (9 authors)
Journal of Cellular Biochemistry
Published: Mar 2019
21 citations
21 citations
1465 days before retraction
MicroRNA‑708 inhibits the proliferation and invasion of osteosarcoma cells by directly targeting ZEB1
Jun He, Xiang Deng, Yanshui Lin
Molecular Medicine Reports
Open Access
Published: Mar 2019
6 citations
6 citations
1484 days before retraction
MicroR-542-3p can mediate ILK and further inhibit cell proliferation, migration and invasion in osteosarcoma cells
Wei Cai, Yong Xu, Wenshan Zuo et al. (4 authors)
Aging
Open Access
Published: Jan 2019
20 citations
20 citations
1538 days before retraction
A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation
Laura Giunti, Martina Da Ros, Veronica De Gregorio et al. (10 authors)
Molecular and Clinical Oncology
Open Access
Published: Jan 2019
16 citations
16 citations
1547 days before retraction
Emerging Roles of Circular RNAs in Osteosarcoma
Chenyu Wang, Ming Ren, Xin Zhao et al. (5 authors)
Medical Science Monitor
Open Access
Published: Oct 2018
37 citations
37 citations
1637 days before retraction
LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer
Dezhi Cheng, Chunchun Bao, Xiu-Xing Zhang et al. (6 authors)
Biomedicine & Pharmacotherapy
Published: Sep 2018
38 citations
38 citations
1666 days before retraction
From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma
Dylan C. Dean, Shen Shen, Francis J. Hornicek et al. (4 authors)
Cancer and Metastasis Reviews
Published: Aug 2018
69 citations
69 citations
1671 days before retraction
Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms
Lei Chen, Yuhang Zhang, Zhenghua Zhang et al. (5 authors)
Molecular Therapy — Methods & Clinical Development
Open Access
Published: Jun 2018
38 citations
38 citations
1742 days before retraction
MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway
Shen Wu, Nanping Ai, Qian Liu et al. (4 authors)
Oncology Reports
Open Access
Published: Mar 2018
18 citations
18 citations
1847 days before retraction
Quick Stats
Total Citations:
31
Years Since Retraction:
2.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025